2 most recent filings and news items mentioning CRDF. Updated every 60 seconds.
OtherJul 16, 2026Neutral
Cardiff Oncology filed a warrant agreement related to its July 2026 securities purchase. The document outlines the terms for investors to purchase common stock starting in 2027.
View filing at SEC.gov →
RegulatoryJun 3, 2026Positive
Cardiff Oncology released interim results from its randomized Phase 2 CRDF-004 trial evaluating onvansertib combined with standard chemotherapy and bevacizumab for first-line RAS-mutated metastatic colorectal cancer. The trial data may impact the company's clinical development pa
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.